| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.93e-07 | 28 | 109 | 5 | GO:0140326 | |
| GeneOntologyMolecularFunction | floppase activity | 1.45e-06 | 16 | 109 | 4 | GO:0140328 | |
| GeneOntologyMolecularFunction | flippase activity | 1.89e-06 | 17 | 109 | 4 | GO:0140327 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 5.45e-06 | 7 | 109 | 3 | GO:0015247 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 8.50e-06 | 51 | 109 | 5 | GO:0140303 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 5.28e-05 | 74 | 109 | 5 | GO:0005548 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 5.51e-05 | 14 | 109 | 3 | GO:0140333 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 6.10e-05 | 124 | 109 | 6 | GO:0101005 | |
| GeneOntologyMolecularFunction | actin binding | CEACAM8 IMPACT MEFV KLHL20 DST MED28 MYO1F TLN2 TAGLN2 DMD MYO16 | 6.25e-05 | 479 | 109 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | ceramide floppase activity | 8.83e-05 | 3 | 109 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | OBSCN SIRPA GPRC5A ITGA7 ITGAM ARHGEF16 DST PTPRM TLN2 TAGLN2 DMD CNTN1 | 1.05e-04 | 599 | 109 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 1.06e-04 | 137 | 109 | 6 | GO:0019783 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 1.76e-04 | 4 | 109 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 2.92e-04 | 5 | 109 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR OBSCN CEACAM8 IMPACT MEFV KLHL20 CCDC66 DST ALMS1 MED28 MYO1F TLN2 TAGLN2 DMD HSPA2 MYO16 | 3.03e-04 | 1099 | 109 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 4.05e-04 | 114 | 109 | 5 | GO:0004843 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 6.09e-04 | 7 | 109 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 7.26e-04 | 196 | 109 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 8.09e-04 | 8 | 109 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.04e-03 | 9 | 109 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.26e-03 | 86 | 109 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.38e-03 | 88 | 109 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | calcium ion binding | UNC13B PRRG1 LALBA CPNE6 FAT1 DST HMCN1 USP32 CRNN ANXA9 CRB2 | 2.62e-03 | 749 | 109 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | integrin binding | 2.74e-03 | 175 | 109 | 5 | GO:0005178 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid translocation | 2.54e-06 | 6 | 105 | 3 | GO:0061092 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid translocation | 4.42e-06 | 7 | 105 | 3 | GO:0061091 | |
| GeneOntologyBiologicalProcess | aminophospholipid translocation | 4.42e-06 | 7 | 105 | 3 | GO:0140331 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 8.83e-06 | 55 | 105 | 5 | GO:0045332 | |
| GeneOntologyBiologicalProcess | aminophospholipid transport | 1.05e-05 | 9 | 105 | 3 | GO:0015917 | |
| GeneOntologyBiologicalProcess | lipid translocation | 1.36e-05 | 60 | 105 | 5 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 2.01e-05 | 65 | 105 | 5 | GO:0097035 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid transport | 5.58e-05 | 15 | 105 | 3 | GO:2001140 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid transport | 6.84e-05 | 16 | 105 | 3 | GO:2001138 | |
| GeneOntologyBiologicalProcess | lactose metabolic process | 7.68e-05 | 3 | 105 | 2 | GO:0005988 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 7.68e-05 | 3 | 105 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | response to ether | 1.84e-04 | 22 | 105 | 3 | GO:0045472 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 2.09e-04 | 106 | 105 | 5 | GO:0015914 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage inflammatory protein 1 alpha production | 2.54e-04 | 5 | 105 | 2 | GO:0071641 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 2.54e-04 | 5 | 105 | 2 | GO:0099039 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 4.81e-05 | 14 | 109 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | cell-cell junction | COL17A1 SDCCAG8 OBSCN CEACAM8 ABCB1 ABCB4 FAT1 DST HMCN1 PTPRM TLN2 CRB2 | 6.03e-05 | 591 | 109 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | specific granule membrane | 1.14e-04 | 91 | 109 | 5 | GO:0035579 | |
| GeneOntologyCellularComponent | anchoring junction | COL17A1 SDCCAG8 OBSCN CEACAM8 ITGA7 ABCB1 ABCB4 FAT1 DST HMCN1 PTPRM TLN2 DMD ARHGAP21 CRB2 | 1.64e-04 | 976 | 109 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | condensed chromosome | 2.08e-04 | 307 | 109 | 8 | GO:0000793 | |
| GeneOntologyCellularComponent | chromosomal region | 3.61e-04 | 421 | 109 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 3.99e-04 | 6 | 109 | 2 | GO:0098591 | |
| GeneOntologyCellularComponent | muscle tendon junction | 3.99e-04 | 6 | 109 | 2 | GO:0005927 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 5.77e-04 | 73 | 109 | 4 | GO:0070821 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 6.13e-04 | 32 | 109 | 3 | GO:0005721 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 6.14e-04 | 276 | 109 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 9.47e-04 | 9 | 109 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.44e-03 | 11 | 109 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | specific granule | 1.52e-03 | 160 | 109 | 5 | GO:0042581 | |
| GeneOntologyCellularComponent | heterochromatin | 1.94e-03 | 101 | 109 | 4 | GO:0000792 | |
| Domain | ConA-like_dom | 2.68e-04 | 219 | 107 | 7 | IPR013320 | |
| Domain | CH | 5.27e-04 | 65 | 107 | 4 | SM00033 | |
| Domain | CH | 6.98e-04 | 70 | 107 | 4 | PF00307 | |
| Domain | - | 7.37e-04 | 71 | 107 | 4 | 1.10.418.10 | |
| Domain | CH | 8.18e-04 | 73 | 107 | 4 | PS50021 | |
| Domain | CH-domain | 9.05e-04 | 75 | 107 | 4 | IPR001715 | |
| Domain | IQ | 1.21e-03 | 81 | 107 | 4 | SM00015 | |
| Domain | Integrin_alpha | 1.73e-03 | 11 | 107 | 2 | PF00357 | |
| Domain | IQ_motif_EF-hand-BS | 1.78e-03 | 90 | 107 | 4 | IPR000048 | |
| Domain | IQ | 2.01e-03 | 93 | 107 | 4 | PS50096 | |
| Domain | Annexin | 2.83e-03 | 14 | 107 | 2 | IPR001464 | |
| Domain | PP2C_SIG | 2.83e-03 | 14 | 107 | 2 | SM00331 | |
| Domain | P_typ_ATPase_c | 2.83e-03 | 14 | 107 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 2.83e-03 | 14 | 107 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 2.83e-03 | 14 | 107 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 2.83e-03 | 14 | 107 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 2.83e-03 | 14 | 107 | 2 | PF16209 | |
| Domain | MAM_1 | 3.70e-03 | 16 | 107 | 2 | PS00740 | |
| Domain | Integrin_alpha_C_CS | 3.70e-03 | 16 | 107 | 2 | IPR018184 | |
| Domain | - | 4.07e-03 | 56 | 107 | 3 | 3.50.50.60 | |
| Domain | MAM | 4.18e-03 | 17 | 107 | 2 | SM00137 | |
| Domain | FAD/NAD-binding_dom | 4.27e-03 | 57 | 107 | 3 | IPR023753 | |
| Domain | MAM | 4.69e-03 | 18 | 107 | 2 | PF00629 | |
| Domain | Integrin_alpha-2 | 4.69e-03 | 18 | 107 | 2 | IPR013649 | |
| Domain | MAM_dom | 4.69e-03 | 18 | 107 | 2 | IPR000998 | |
| Domain | INTEGRIN_ALPHA | 4.69e-03 | 18 | 107 | 2 | PS00242 | |
| Domain | Integrin_alpha2 | 4.69e-03 | 18 | 107 | 2 | PF08441 | |
| Domain | Integrin_alpha | 4.69e-03 | 18 | 107 | 2 | IPR000413 | |
| Domain | MAM_2 | 4.69e-03 | 18 | 107 | 2 | PS50060 | |
| Domain | Int_alpha | 5.22e-03 | 19 | 107 | 2 | SM00191 | |
| Domain | Int_alpha_beta-p | 5.22e-03 | 19 | 107 | 2 | IPR013519 | |
| Pubmed | TPR ZSCAN4 BCORL1 IDH3A INPP5F ZNF462 DST ALMS1 UBR5 SEC16A ARHGAP21 | 8.86e-08 | 418 | 109 | 11 | 34709266 | |
| Pubmed | 5.87e-07 | 225 | 109 | 8 | 12168954 | ||
| Pubmed | MIS18BP1 CENPC BCORL1 CCDC66 DST ALMS1 MED28 MED22 SEC16A PIP4K2B TAGLN2 SUZ12 | 9.12e-07 | 645 | 109 | 12 | 25281560 | |
| Pubmed | EDC3 CEP192 INPP5F LRCH3 DST ALMS1 UBR5 SEC16A USP54 TRAPPC9 | 1.50e-06 | 446 | 109 | 10 | 24255178 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | COL17A1 SIRPA GPRC5A ARHGEF16 ABCB1 FAT1 PTPRM USP32 CRNN ATP11A ARHGAP21 | 1.85e-06 | 569 | 109 | 11 | 30639242 |
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 37149635 | ||
| Pubmed | 3.54e-06 | 10 | 109 | 3 | 22895009 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPR EDC3 AHCTF1 INPP5F PRPF8 DST SEC16A TLN2 TAGLN2 ARHGAP21 | 3.98e-06 | 498 | 109 | 10 | 36634849 |
| Pubmed | 4.54e-06 | 209 | 109 | 7 | 36779422 | ||
| Pubmed | 6.45e-06 | 12 | 109 | 3 | 21914794 | ||
| Pubmed | 7.28e-06 | 147 | 109 | 6 | 29576527 | ||
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 9.23e-06 | 233 | 109 | 7 | 32290105 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10488067 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 9.73e-06 | 2 | 109 | 2 | 21705081 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10552998 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28441502 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 9.73e-06 | 2 | 109 | 2 | 9196326 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16611225 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22184139 | ||
| Pubmed | Isolation and expression of a complementary DNA that confers multidrug resistance. | 9.73e-06 | 2 | 109 | 2 | 3022150 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 2570420 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8898203 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 2473069 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28274756 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19185004 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18215618 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24676719 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23686079 | ||
| Pubmed | Cryo-EM structures capture the transport cycle of the P4-ATPase flippase. | 9.73e-06 | 2 | 109 | 2 | 31416931 | |
| Pubmed | What have we learnt thus far from mice with disrupted P-glycoprotein genes? | 9.73e-06 | 2 | 109 | 2 | 8763339 | |
| Pubmed | Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. | 9.73e-06 | 2 | 109 | 2 | 9473291 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 2471060 | ||
| Pubmed | Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. | 9.73e-06 | 2 | 109 | 2 | 17920818 | |
| Pubmed | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 9.73e-06 | 2 | 109 | 2 | 18231753 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 31329944 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16476707 | ||
| Pubmed | ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. | 9.73e-06 | 2 | 109 | 2 | 32058310 | |
| Pubmed | CENP-C facilitates the recruitment of M18BP1 to centromeric chromatin. | 9.73e-06 | 2 | 109 | 2 | 22540025 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 3768958 | ||
| Pubmed | Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. | 9.73e-06 | 2 | 109 | 2 | 38522903 | |
| Pubmed | Influence of GPRC5A-Regulated ABCB1 Expression on Lung Adenocarcinoma Proliferation. | 9.73e-06 | 2 | 109 | 2 | 38426412 | |
| Pubmed | Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. | 9.73e-06 | 2 | 109 | 2 | 3477522 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16857572 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 1512460 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 1969609 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24140176 | ||
| Pubmed | Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. | 9.73e-06 | 2 | 109 | 2 | 9419367 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 2248681 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 29575196 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 17440929 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 7832992 | ||
| Pubmed | What's new in the pathogeneses and triggering factors of bullous pemphigoid. | 9.73e-06 | 2 | 109 | 2 | 36412277 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11826402 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10453001 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIS18BP1 EDC3 SDCCAG8 CEP192 CCDC66 ALMS1 MEIOC UBR5 USP54 HSPA2 ARHGAP21 ELL | 1.56e-05 | 853 | 109 | 12 | 28718761 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPR LRWD1 EDC3 CENPC AHCTF1 DTL CEP192 GPRC5A PRPF8 UBR5 CTCF TLN2 TAGLN2 LSM8 | 1.56e-05 | 1155 | 109 | 14 | 20360068 |
| Pubmed | 1.63e-05 | 16 | 109 | 3 | 29764992 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | UNC13B EDC3 DTL CEP192 IDH3A PRPF8 KLHL20 UBR5 USP32 ZNF770 TAGLN2 LSM8 ELL | 1.64e-05 | 1005 | 109 | 13 | 19615732 |
| Pubmed | TPR ZC3H14 MIS18BP1 EDC3 CENPC UPF1 PRPF8 TXNRD1 UBR5 CTCF MED28 MED22 SUZ12 | 1.80e-05 | 1014 | 109 | 13 | 32416067 | |
| Pubmed | 2.02e-05 | 263 | 109 | 7 | 34702444 | ||
| Pubmed | Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. | 2.91e-05 | 3 | 109 | 2 | 7814632 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 9778357 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 8547326 | ||
| Pubmed | Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. | 2.91e-05 | 3 | 109 | 2 | 16684813 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 19179609 | ||
| Pubmed | An essential role for talin during alpha(M)beta(2)-mediated phagocytosis. | 2.91e-05 | 3 | 109 | 2 | 17202407 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18662993 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 26255671 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25029804 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 30086173 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 24732756 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 21216283 | ||
| Pubmed | β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice. | 2.91e-05 | 3 | 109 | 2 | 22180459 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 2045679 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 9542318 | ||
| Pubmed | Destabilization of mRNAs enhances competence to initiate meiosis in mouse spermatogenic cells. | 2.91e-05 | 3 | 109 | 2 | 38884383 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 21536749 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 35017527 | ||
| Pubmed | Structural and functional characterization of the mouse multidrug resistance gene family. | 2.91e-05 | 3 | 109 | 2 | 1980424 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CEACAM8 GPRC5A ITGAM ABCB1 ABCB4 CPNE6 KRT24 ATP8A1 HMCN1 TAGLN2 C5 CRB2 CNTN1 | 3.14e-05 | 1070 | 109 | 13 | 23533145 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | TPR ZC3H14 EDC3 CENPC UPF1 PRPF8 USP32 SEC16A TAGLN2 HSPA2 LSM8 ARHGAP21 | 3.34e-05 | 922 | 109 | 12 | 27609421 |
| Pubmed | 3.67e-05 | 396 | 109 | 8 | 26687479 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ZC3H14 EDC3 AHCTF1 UPF1 PRPF8 DST ALMS1 CTCF SEC16A TAGLN2 ARHGAP21 | 3.78e-05 | 934 | 109 | 12 | 33916271 |
| Pubmed | 4.09e-05 | 653 | 109 | 10 | 22586326 | ||
| Pubmed | TPR SIRPA UPF1 ZNF462 DST UBR5 CTCF SEC16A TLN2 ADGRA1 ARHGAP21 CNTN1 | 5.07e-05 | 963 | 109 | 12 | 28671696 | |
| Pubmed | 5.45e-05 | 210 | 109 | 6 | 16565220 | ||
| Pubmed | Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. | 5.82e-05 | 4 | 109 | 2 | 9427295 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 26000482 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 25504048 | ||
| Pubmed | Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy. | 5.82e-05 | 4 | 109 | 2 | 18252718 | |
| Pubmed | Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes. | 5.82e-05 | 4 | 109 | 2 | 14668477 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 22798625 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 8954775 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 2069718 | ||
| Pubmed | Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy. | 5.82e-05 | 4 | 109 | 2 | 24631023 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 7.26e-05 | 322 | 109 | 7 | 39098523 | |
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 7.39e-05 | 26 | 109 | 3 | 14654843 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EDC3 DTL CEP192 INPP5F ARHGEF16 DST ALMS1 SEC16A USP54 ARHGAP21 TRAPPC9 | 8.51e-05 | 861 | 109 | 11 | 36931259 |
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 19416897 | ||
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 26567335 | ||
| Interaction | NINL interactions | NCAPD3 MIS18BP1 SDCCAG8 CEP192 CCDC66 ALMS1 MEIOC UBR5 CC2D2A USP54 HSPA2 ARHGAP21 | 7.02e-06 | 458 | 109 | 12 | int:NINL |
| GeneFamily | ATP binding cassette subfamily B | 9.60e-04 | 11 | 77 | 2 | 806 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.05e-03 | 181 | 77 | 5 | 694 | |
| GeneFamily | Ubiquitin specific peptidases | 1.75e-03 | 56 | 77 | 3 | 366 | |
| GeneFamily | ATPase phospholipid transporting | 1.81e-03 | 15 | 77 | 2 | 1210 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.62e-03 | 18 | 77 | 2 | 1160 | |
| GeneFamily | Fibronectin type III domain containing | 4.84e-03 | 160 | 77 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.95e-03 | 161 | 77 | 4 | 593 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.65e-07 | 176 | 109 | 7 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-07 | 184 | 109 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-07 | 184 | 109 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-07 | 184 | 109 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.58e-07 | 184 | 109 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.67e-07 | 197 | 109 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.67e-07 | 197 | 109 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.27e-07 | 200 | 109 | 7 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-07 | 200 | 109 | 7 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.22e-07 | 130 | 109 | 6 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.91e-06 | 170 | 109 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.47e-06 | 174 | 109 | 6 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-06 | 179 | 109 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.35e-06 | 185 | 109 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.35e-06 | 185 | 109 | 6 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-06 | 186 | 109 | 6 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.55e-06 | 186 | 109 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-06 | 186 | 109 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.55e-06 | 186 | 109 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.75e-06 | 187 | 109 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.96e-06 | 188 | 109 | 6 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.40e-06 | 190 | 109 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.85e-06 | 192 | 109 | 6 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.09e-06 | 193 | 109 | 6 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 8.09e-06 | 193 | 109 | 6 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.33e-06 | 194 | 109 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 196 | 109 | 6 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 196 | 109 | 6 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 196 | 109 | 6 | 27364b577d77aefaa147abb346c46fce61e28ec3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 9.09e-06 | 197 | 109 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 9.09e-06 | 197 | 109 | 6 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.09e-06 | 197 | 109 | 6 | 01e9505d947e5a5f005d1eab96301f84fc194809 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.09e-06 | 197 | 109 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.09e-06 | 197 | 109 | 6 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 198 | 109 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.36e-06 | 198 | 109 | 6 | 1851b7f4198b42c21c934e2fbda39dbd65e2625c | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 198 | 109 | 6 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 9.36e-06 | 198 | 109 | 6 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 198 | 109 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 198 | 109 | 6 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | 9.63e-06 | 199 | 109 | 6 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.63e-06 | 199 | 109 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-06 | 199 | 109 | 6 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 109 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 9.91e-06 | 200 | 109 | 6 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.91e-06 | 200 | 109 | 6 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.91e-06 | 200 | 109 | 6 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 109 | 6 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.91e-06 | 200 | 109 | 6 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 118 | 109 | 5 | 8d96a4879b28979fa04fbaeffa271a6b9ecbe867 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 127 | 109 | 5 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.53e-05 | 141 | 109 | 5 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.53e-05 | 141 | 109 | 5 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.47e-05 | 75 | 109 | 4 | 3167beedef7304697e9577270cdeacfc9743cee1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.47e-05 | 75 | 109 | 4 | 70c346f92a9ac7e33fc1b9dee1dca0bf9ae0a38c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.47e-05 | 75 | 109 | 4 | 26d6e54ed0a6c3ff57f6269c460177bc7b8bf979 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-05 | 153 | 109 | 5 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb-Excitatory_Neuron.Sc17a7.Rorb-BC006965_(Layer_5a,_BC006965+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.70e-05 | 81 | 109 | 4 | 9de04f435b5acbfb1d709103db35e56e8ac97a85 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.77e-05 | 161 | 109 | 5 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 5.06e-05 | 163 | 109 | 5 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | f751cbd01d4978ded7755874ab60504f6291afd7 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-05 | 168 | 109 | 5 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.01e-05 | 169 | 109 | 5 | 15d5758d94a14a909d1d0c8bba9ce497a33d1512 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.01e-05 | 169 | 109 | 5 | c6750c45c44be68aea39e918ba97c6f875ccea34 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.35e-05 | 171 | 109 | 5 | 6a2f88c2a62cb2f69797804e24eb1137a3e148de | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.35e-05 | 171 | 109 | 5 | 9be3554626408bb897d1f1c43b3ab4a92651f2e2 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.35e-05 | 171 | 109 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-05 | 174 | 109 | 5 | 911eac6f6ec1e5e85348a7fe774243498388a810 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 6.89e-05 | 174 | 109 | 5 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.08e-05 | 175 | 109 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.08e-05 | 175 | 109 | 5 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 176 | 109 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.47e-05 | 177 | 109 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.47e-05 | 177 | 109 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-05 | 177 | 109 | 5 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.47e-05 | 177 | 109 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-05 | 177 | 109 | 5 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | lung|World / shred on tissue and cell subclass | 7.68e-05 | 178 | 109 | 5 | 7b1e371272328d6b6c3994382d64281ffc737db2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.88e-05 | 179 | 109 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.88e-05 | 179 | 109 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.88e-05 | 179 | 109 | 5 | fa58fa0901eadb170e3d2facb2a3d8c5e624329a | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 8.30e-05 | 181 | 109 | 5 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 181 | 109 | 5 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-05 | 181 | 109 | 5 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 8.30e-05 | 181 | 109 | 5 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 181 | 109 | 5 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.52e-05 | 182 | 109 | 5 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.97e-05 | 184 | 109 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.97e-05 | 184 | 109 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.97e-05 | 184 | 109 | 5 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 8.97e-05 | 184 | 109 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.97e-05 | 184 | 109 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 9.20e-05 | 185 | 109 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.20e-05 | 185 | 109 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 9.20e-05 | 185 | 109 | 5 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.44e-05 | 186 | 109 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.68e-05 | 187 | 109 | 5 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.68e-05 | 187 | 109 | 5 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.68e-05 | 187 | 109 | 5 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-05 | 187 | 109 | 5 | dba4924d914a7dcd4901142684ba920c2404860b | |
| Disease | complement C5 measurement | 3.75e-05 | 3 | 105 | 2 | EFO_0020278 | |
| Disease | Duchenne muscular dystrophy (is_implicated_in) | 3.75e-05 | 3 | 105 | 2 | DOID:11723 (is_implicated_in) | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.20e-04 | 27 | 105 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | electroencephalogram measurement | 1.44e-04 | 74 | 105 | 4 | EFO_0004357 | |
| Disease | selenium measurement | 1.50e-04 | 29 | 105 | 3 | EFO_0006331 | |
| Disease | Colorectal Carcinoma | UNC13B OBSCN ABCB1 ABCB4 TXNRD1 FAT1 CSRNP3 DMD CNTN1 PDZRN4 | 2.06e-04 | 702 | 105 | 10 | C0009402 |
| Disease | neutropenia (implicated_via_orthology) | 2.60e-04 | 7 | 105 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 4.44e-04 | 9 | 105 | 2 | EFO_0004606 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 4.44e-04 | 9 | 105 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | familial Mediterranean fever (is_implicated_in) | 4.44e-04 | 9 | 105 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | liver cirrhosis (is_implicated_in) | 4.87e-04 | 43 | 105 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | Hypermetropia | 5.11e-04 | 103 | 105 | 4 | HP_0000540 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 6.76e-04 | 11 | 105 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | N-acetyl-2-aminooctanoate measurement | 8.09e-04 | 12 | 105 | 2 | EFO_0800567 | |
| Disease | putamen volume change measurement | 9.54e-04 | 13 | 105 | 2 | EFO_0021495 | |
| Disease | Bardet-Biedl Syndrome | 9.54e-04 | 13 | 105 | 2 | C0752166 | |
| Disease | Disorder of eye | 9.85e-04 | 212 | 105 | 5 | C0015397 | |
| Disease | Intrahepatic cholestasis of pregnancy | 1.46e-03 | 16 | 105 | 2 | EFO_0009048 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.74e-03 | 670 | 105 | 8 | EFO_0006335, EFO_0006336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SISSSGQEIQQYISE | 1006 | Q9UMD9 | |
| NREVVNTELGSYRDS | 1366 | Q9Y6Y1 | |
| QLRQLSQGSEEYETT | 556 | P55199 | |
| SQGSEEYETTRGQIL | 561 | P55199 | |
| VATTSVEELQGAYEN | 126 | P49711 | |
| NVTRNDTGSYTLQVI | 111 | P31997 | |
| DGDTNTSTQEVVQYN | 66 | Q2KHT4 | |
| QTGEYLTEQEDEQRR | 1341 | Q5H9F3 | |
| AATNIRNYGTEDEDT | 151 | Q86SQ6 | |
| VYQGNSRTQISDTNV | 121 | Q8TCU4 | |
| YQEIQERGLNTSQES | 216 | Q5VV41 | |
| QQITVSLAQGYERTS | 276 | P11532 | |
| NEEGFVRLYNTESQS | 71 | Q9NZJ0 | |
| ENGIVSQSEVIRAYD | 1141 | Q9Y2Q0 | |
| TIVAEEVSGTNDYVQ | 141 | O95741 | |
| ELLSTVETNNGQENY | 986 | Q09MP3 | |
| ENRAYSQEEITQGFE | 296 | Q8NFJ5 | |
| SQDTLGSVELQYNES | 591 | Q6ZMN7 | |
| VTEQAIQYGTEDNST | 326 | Q8N3J5 | |
| SQVESDTGDRKQIYN | 336 | P35557 | |
| DASSTYSQVENLNRE | 126 | Q9UFC0 | |
| TQQSSGYSEDLNEIE | 671 | Q7Z304 | |
| IAYGDNSRVVSQEEI | 1131 | P08183 | |
| DSEEINRQVTYFITG | 2946 | Q14517 | |
| EGSSEISQRVQSRNY | 831 | Q6ZMT4 | |
| ESQYQENRGSLVVTN | 351 | Q96II8 | |
| ENQTDTAQRATTTYD | 511 | Q6P0N0 | |
| YLNQTIQDDASTGER | 621 | Q9Y6X6 | |
| RRQSEGTYSPSQQEV | 1251 | Q5IJ48 | |
| SENILTNYENQSRVE | 2151 | Q03001 | |
| TNYENQSRVETNERA | 2156 | Q03001 | |
| TQVSRATQGEQDNYE | 46 | Q15528 | |
| INYEGQNTVAVSETD | 101 | Q8WX39 | |
| TPNQISENYSERDTV | 446 | Q8WYN3 | |
| AGYTTESGRQEEQTT | 61 | P05160 | |
| DNQSSVLVQVYEGER | 436 | P54652 | |
| ELREISGNQYVNEVT | 91 | Q8N4E4 | |
| QLEQETGIQTGYTRT | 111 | Q8NCN5 | |
| DTEAGYVAQLSEIQT | 391 | Q2M2I5 | |
| DTQAIVENNESTEYG | 56 | P00709 | |
| YVTENGVSQREETDL | 1746 | P09848 | |
| IQEYSTQENGTDDSA | 91 | O15553 | |
| SQDYVNGTDQEEIRT | 61 | Q9H204 | |
| QYQRSTGQELEEAVQ | 236 | O76027 | |
| YQGRVSAVDQVSQTI | 21 | Q96F86 | |
| SNSLEEIYIQNIGES | 86 | Q9P2X3 | |
| SYDRQAESQSQERIS | 166 | Q9UBG3 | |
| AEGTVTEDYNSQVVR | 456 | Q8IZP7 | |
| IRSTEGHYTVNENSQ | 4171 | Q96RW7 | |
| NIAYGDNSRVVSQDE | 1136 | P21439 | |
| TRLSQQQEGTTYSLV | 6401 | Q5VST9 | |
| YESIQQTARSIAEQA | 246 | Q8NI37 | |
| TYNGDIRETRTDQEN | 381 | Q96T49 | |
| QGQLTETSVRSYEDQ | 486 | Q8IUM7 | |
| QIDVALSQDSTYQGE | 1101 | Q92900 | |
| NIVTIRENTEGEYSG | 141 | P50213 | |
| AYTSQITVEEGNVQT | 126 | Q9Y2M5 | |
| VERTQQEVDSQSYSR | 151 | Q9P2K1 | |
| GSSQNRIRDSEYEIQ | 241 | Q03188 | |
| STQDTINAIEGLTEY | 1286 | P01031 | |
| VVTSADGENLEIQSY | 2306 | Q8N3K9 | |
| EEAANRVQVTSQEYS | 851 | Q12860 | |
| SYERENLISGSNQTE | 821 | A2RUB6 | |
| REVTYSRSTGENEQV | 51 | Q9HAW0 | |
| TSNNIREIEIDYTGT | 71 | Q9NV96 | |
| ENYINRTVAVITSDG | 6 | O95777 | |
| TAAIVYVENGESENQ | 841 | Q8TEP8 | |
| YVENGESENQESFRT | 846 | Q8TEP8 | |
| QTRQGEGNSTYSEEQ | 56 | Q9H819 | |
| NVEDGRASIYQSVVT | 46 | Q99518 | |
| YEVTVSNQGQSLRTL | 886 | Q13683 | |
| SENIYSDVRGLSQNQ | 1786 | Q8WYP5 | |
| TYDLTNSVQRQSTGE | 181 | Q9Y2H2 | |
| QEEEQLRAQGSTDYF | 56 | Q5SRE7 | |
| RLQTIEGDTNSDYIN | 941 | P28827 | |
| TSQSEDNVDLRQTYT | 66 | A2RUB1 | |
| ERYGINTTDIFQTVD | 101 | P37802 | |
| LADTQQREASAYEQV | 326 | Q86SQ7 | |
| GIDDQDYQNSVTRSA | 111 | P78356 | |
| IRNGSIYINESQATE | 206 | Q9UK23 | |
| NAREITQDTNDITYA | 416 | P78324 | |
| NVTVTVRNDGEDSYR | 801 | P11215 | |
| SGRYDTQEDFSVVLQ | 961 | Q6P1J6 | |
| EIENIQTYQSTAEEN | 661 | Q8TBZ0 | |
| QVSSYSLEQESNGEI | 1391 | P42695 | |
| VNTSDLNEELGQVEY | 396 | P98196 | |
| GDEIITSTTSNYETQ | 2051 | Q6P2Q9 | |
| AQSTNSEEIIEGEYN | 421 | Q16881 | |
| TQYTEQDSVVTARGL | 121 | Q9BRP9 | |
| SDGIVVSNDTYRDLQ | 236 | Q5D1E8 | |
| VSNDTYRDLQGERQE | 241 | Q5D1E8 | |
| TVNTEENVYATLGSD | 26 | P40200 | |
| VGGETDETTVSQNYR | 571 | O15027 | |
| DETTVSQNYRGSVSQ | 576 | O15027 | |
| STDGEVETQVYNQDS | 1876 | P12270 | |
| VETQVYNQDSQDSIG | 1881 | P12270 | |
| TRYSTNISSNVGEEV | 496 | C9JQI7 | |
| SEDGEVEQQRTYSSG | 546 | Q15022 | |
| LGADNEYSSQEESQR | 151 | O14795 | |
| RTQENYEGNEEVSSP | 2536 | O00507 | |
| LISGEQSSEQTQRTF | 371 | Q6IQ21 | |
| QTSQDTSLETGQGYE | 176 | Q8NAM6 | |
| GVNQDVEYSSITDQQ | 1451 | Q7Z4N2 | |
| LRSQVLQSEDEQGSY | 81 | Q8N9V2 | |
| TYEEATGQVNLQRSE | 171 | O14668 | |
| NFERINTVQYGTSDN | 61 | Q96AP4 | |
| YSVQTTEGEQISQLI | 381 | Q9Y4G6 | |
| SYVVEQQEGLNTESQ | 961 | Q96JM2 | |
| DEISTNVSVQLYNGE | 716 | Q96Q05 | |
| YILAVNDQETGSDTT | 756 | Q5T5U3 | |
| QESKTTNVRQTYDDG | 136 | Q6PJT7 | |
| EQVEDRIGSSLSYVN | 441 | Q8NFA0 | |
| TAQTYSELQGERIVS | 461 | O95071 | |
| SDSQGTVIYNVENDS | 416 | Q70EL1 | |
| LNQSDTYQVDGTDDR | 236 | O00160 | |
| RDQGYSEVVLDTSNI | 166 | Q9UHF3 |